Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenqi Huafen Pian (参芪花粉片) is a traditional Chinese medicine formulated as a sugar-coated tablet. It is composed of several herbal ingredients, including Codonopsis (党参), Astragalus (黄芪), Typha pollen (蒲黄), Rapeseed pollen (油菜花粉), Corn pollen (玉米花粉), and Sunflower pollen (向日葵花粉). This medicine is primarily indicated for symptoms associated with spleen and lung qi deficiency syndrome, such as fatigue, shortness of breath, dizziness, memory loss, poor appetite, and sore waist and knees. It is also used to assist in regulating the body for those with weak constitution, low immunity, and chronic fatigue, and is applicable to patients with high altitude sickness and hypoxia after exercise.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenqi Huafen Pian.